Latest Strategic Collaborations News

Avecho Biotechnology advances its pivotal Phase III CBD insomnia trial with 160 patients dosed and secures $2.5 million to accelerate manufacturing and regulatory efforts ahead of a 2026 interim analysis.

NoviqTech Limited has launched Fuel Central for sustainable fuels traceability and established Quantum Intelligence Pty Ltd to advance quantum computing and AI applications, backed by a $1.08 million placement. The company also refreshed its board and expanded its international footprint.

Altech Batteries has launched immediate sales of sodium nickel chloride batteries through a strategic collaboration with AMPower, while advancing its flagship CERENERGY project in Germany with strong funding and prototype milestones.

Bellavista Resources confirms successful initial bioleaching tests at its Brumby deposit, recovering key critical minerals, while progressing due diligence on over 50 potential projects to expand its portfolio.

Scorpion Minerals reports promising shallow gold intercepts at its Pharos Project and announces a strategic collaboration with Gylden Resources, enhancing processing options in Western Australia’s Murchison region.

Adslot Ltd reports solid progress in Q1 FY26, highlighting growth in its StoreFront and Marketplace platforms alongside a successful $989,000 capital raise to fuel expansion.

Cauldron Energy has taken a significant step forward at its Yanrey Uranium Project by signing a non-binding MOU with Uzbekistan’s Navoiyuran, while preparing for a major drilling campaign amid a shifting regulatory landscape in Western Australia.

Orbital Corporation Ltd reports a robust Q1 2025 with increased revenues, successful prototype completion of a new 350cc heavy fuel engine, and strategic partnerships positioning it for growth in the evolving UAV market.

Tennant Minerals has announced a maiden high-grade copper-gold-silver-bismuth Mineral Resource at its Bluebird discovery, revealing strong early open-pit potential and significant underground upside. New geophysical modelling points to major extensions, underpinning plans for long-term development within the Tennant Creek Copper Alliance.

Cambium Bio has locked in a significant R&D tax rebate and forged three strategic partnerships, underpinning its Phase 3 clinical trials for its lead ophthalmology biologic. The company’s recent capital raise further strengthens its runway as it prepares for pivotal trial milestones.

Amaero Ltd reports a remarkable 445% increase in quarterly revenue driven by powder sales and manufacturing scale-up, alongside securing a US$22.8 million loan and exclusive supply agreements with key defense and aerospace players.

Imagion Biosystems has made significant strides toward filing an IND application for its MagSense® HER2 breast cancer imaging agent, supported by positive FDA feedback and a recent $3.5 million capital raise to fund upcoming clinical trials.